Skip to Content
Merck
All Photos(1)

Key Documents

679097

Sigma-Aldrich

(R)-(−)-2-Methylpyrrolidine

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C5H11N
CAS Number:
Molecular Weight:
85.15
MDL number:
UNSPSC Code:
12352005
PubChem Substance ID:
NACRES:
NA.22

refractive index

n20/D 1.4353

density

0.842 g/mL at 25 °C (lit.)

storage temp.

2-8°C

SMILES string

C[C@@H]1CCCN1

InChI

1S/C5H11N/c1-5-3-2-4-6-5/h5-6H,2-4H2,1H3/t5-/m1/s1

InChI key

RGHPCLZJAFCTIK-RXMQYKEDSA-N

Looking for similar products? Visit Product Comparison Guide

Application

(R)-(−)-2-Methylpyrrolidine, an optically active amine that can be used as a key building block to synthesize:
  • 4,5-fused pyridazinone derivatives are applicable as potent histamine H3 receptor antagonists.
  • Naphthalenoid histamine H3 receptor antagonist.
  • Pyrrolo[2,3-d]pyrimidine derivatives as potent inhibitors of leucine-rich repeat kinase 2.

Signal Word

Danger

Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral - Flam. Liq. 2 - Skin Corr. 1B

Storage Class Code

3 - Flammable liquids

WGK

WGK 3

Flash Point(F)

45.0 °F - closed cup

Flash Point(C)

7.22 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

Synthesis and evaluation of pyridazinone?phenethylamine derivatives as selective and orally bioavailable histamine H 3 receptor antagonists with robust wake-promoting activity
reddy Dandu, Reddeppa, et al.
Bioorganic & Medicinal Chemistry Letters, 21.21, 6362-6365 (2011)
Identification of pyridazin-3-one derivatives as potent, selective histamine H 3 receptor inverse agonists with robust wake activity
Hudkins, Robert L., et al.
Bioorganic & Medicinal Chemistry Letters, 21.18, 5493-5497 (2011)
Organic Process Research & Development, 11, 1004-1004 (2007)
A new class of potent non-imidazole H 3 antagonists: 2-aminoethylbenzofurans
Cowart, Marlon, et al.
Bioorganic & Medicinal Chemistry Letters, 14.3, 689-693 (2004)
Douglas S Williamson et al.
Journal of medicinal chemistry, 64(14), 10312-10332 (2021-06-30)
Inhibitors of leucine-rich repeat kinase 2 (LRRK2) and mutants, such as G2019S, have potential utility in Parkinson's disease treatment. Fragment hit-derived pyrrolo[2,3-d]pyrimidines underwent optimization using X-ray structures of LRRK2 kinase domain surrogates, based on checkpoint kinase 1 (CHK1) and a

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service